---
title: System Decommissioning Validation: A Practical Guide for GxP Teams
date: 2026-10-19
description: How to validate a system decommissioning in GxP: plan, migrate, verify and archive records so your data stays defensible in the next audit.
author: Qualitum
cover: https://media.babylovegrowth.ai/blog-images/organization-48457/1792233361951_Decommissioned-control-workstation-in-pharmaceutical-production.jpeg
coverAlt: Decommissioned control workstation in pharmaceutical production
---

System decommissioning validation is the documented proof that a GxP system was taken out of service without losing, corrupting or orphaning the records it created. The system can be switched off. The evidence it produced cannot. You have to show that every record was migrated or archived intact, that audit trails and metadata survived, and that the records stay readable for the full retention period.

This guide walks through how to plan that proof, what to test, what to keep, and where teams most often get caught.

## TL;DR

- Decommissioning is a records management project with an IT component, not the reverse. Your success metric is whether the archived data holds up in a future audit.
- Validate the migration or archive, not just the shutdown: completeness, readability, and preserved audit trails and metadata.
- Verify migrated data with objective checks such as checksums. A simple file copy is not evidence.
- Finish with a disposition plan, so inactive records are neither destroyed early nor mixed back into active production environments.
- Scale the effort to risk. A system that touched batch release needs far more rigor than a retired scheduling tool.

## Table of Contents

- [What decommissioning validation actually covers](#what-decommissioning-validation-actually-covers)
- [Compliance does not end at shutdown](#compliance-does-not-end-at-shutdown)
- [A step-by-step approach](#a-step-by-step-approach)
- [Special cases worth planning for](#special-cases-worth-planning-for)
- [Where decommissioning projects go wrong](#where-decommissioning-projects-go-wrong)
- [Why automation is moving into retirement](#why-automation-is-moving-into-retirement)
- [Our perspective](#our-perspective)
- [Where Qualitum fits](#where-qualitum-fits)
- [FAQ](#faq)
- [Sources](#sources)

## What decommissioning validation actually covers

Decommissioning is the planned process of taking a system out of active use. According to FDA records guidance, it requires that [active records are identified, migrated and validated in a new system before the old one is turned off](https://www.fda.gov/media/179376/download). Records that are inactive but still under retention requirements move to an approved recordkeeping system. Nothing is deleted until migration has succeeded and been validated.

The EU framework sets the same logic at the lifecycle level. Annex 11 states that computerised systems [should be validated before use and kept in a validated state throughout their lifecycle](https://health.ec.europa.eu/document/download/40231f18-e564-4043-94de-c031f813d38b_en). Retirement is the last phase of that lifecycle, and it needs the same discipline as the first.

In practice, decommissioning validation answers five questions:

1. Did we identify every record, including audit trails, metadata, electronic signatures and configuration history?
2. Did each record reach its destination complete and unaltered?
3. Can the destination system or archive render those records in a way a reviewer can understand?
4. Who owns the records now, and for how long?
5. Is the whole sequence documented, approved by quality, and traceable to a plan?

### Decommissioning versus retirement

The two words are often used as if they were the same. A useful distinction, drawn in [industry commentary on the Annex 11 revision](https://sqa.org/common/Uploaded%20files/1-regulatory%20resources/regulatory%20communications/2021%20-/RRT_EMA-PICs_Annex11Rev_FINAL_2025-10-06.pdf), is that decommissioning takes a system out of active use, while retirement is the final disposal of the system and its records. Periodic review should continue for a system that has been decommissioned but not yet formally retired. A final, comprehensive review belongs at retirement.

Write that difference into your SOP. It tells your team when the system is still in scope for periodic review and when it is truly closed.

## Compliance does not end at shutdown

The most common misconception is that the obligation stops when the servers go dark. It does not. Audit trails, metadata and the ability to reconstruct data are needed for the length of the retention period. The same SQA commentary frames decommissioning as a records management project, with the defensibility of archived data as the measure of success.

Two consequences follow.

- **Audit trails have a retention clock too.** Regulators, including those working under PIC/S guidance, expect audit trails to be kept at least as long as the electronic records they describe. An archive of final results with no audit trail is a gap, however tidy it looks.
- **Quality owns the outcome.** IT can execute the shutdown. Only the quality unit can decide whether the evidence is sufficient. Assign a records owner in the plan, by role, before work begins.

## A step-by-step approach

### 1. Start with a decommissioning plan and a risk assessment

The plan should name the system, its intended use, the records it holds, retention requirements per record type, the target destination, and the people accountable. The risk assessment sets how deep your verification goes.

Modern FDA thinking supports this proportionality. The agency's [Computer Software Assurance guidance](https://www.fda.gov/media/188844/download) describes a risk-based approach to establishing confidence that software is fit for its intended use, and it considers the risk to safety or quality if the software fails. Apply the same reasoning to retirement. A system that held release data, stability results or sterilization records warrants full verification of every migrated record class. A low-risk utility may justify sampling.

If your team needs a refresher on structuring that assessment, our guide to [inspection ready CSV risk assessment](https://blog.qualitum.ai/csv-risk-assessment) covers FDA CSA and ICH Q9(R1) in detail.

![1. Start with a decommissioning plan and a risk assessment — overview diagram](https://media.babylovegrowth.ai/blog-images/organization-48457/1792233392911_1.-Start-with-a-decommissioning-plan-and-a-risk-assessment-overview-diagram.jpeg)

### 2. Inventory every record and dependency

Build a record inventory before you touch any data. Include:

- Primary data and processed results
- Audit trails and change logs
- Electronic signatures and their manifestations
- User and role history, so you can show who was authorized at the time
- Configuration, version and validation documentation for the system itself
- Interfaces to other systems that read or write the same data

The last item is easy to miss. A retired LIMS may feed a batch record system, a trending tool or a reporting layer. Map those links, then decide what happens to each.

### 3. Choose the end state for each record class

There are usually three options, and different record classes can take different routes.

| Option | Best for | Main validation burden |
|---|---|---|
| Migrate to an active replacement system | Records still used in daily work | Data migration validation, with business meaning preserved |
| Archive in a validated read-only repository | Inactive records under retention | Proof of completeness, readability and access control |
| Keep the legacy system in a read-only state | Complex data that cannot be converted faithfully | Ongoing maintenance, security and periodic review |

No option is exempt from scrutiny. Regulators acknowledge that keeping obsolete operating systems or hardware running is often an [impossible technical hurdle in practice](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/fda-bioresearch-monitoring-information/guidance-industry-computerized-systems-used-clinical-trials), but they offer no exemption. The accepted answer is to validate the archival process itself: show the migrated data stays readable and complete for the retention period, rather than fixating on keeping the original application alive.

### 4. Validate the migration or archive

This is the core of the work. Your protocol should test, at minimum:

- **Completeness:** record counts and key fields reconcile between source and destination.
- **Accuracy:** values, units, timestamps and time zones are unchanged.
- **Integrity:** hash or checksum comparison of source and target. A plain file copy does not prove this, and the [FDA records policy](https://www.fda.gov/media/179376/download) points to checksums for verifying migration integrity.
- **Context:** audit trails, metadata and signature meaning stay linked to the record they belong to.
- **Readability:** a trained reviewer can open, search and interpret the records in the destination, using documented procedures.
- **Access control:** only authorized roles can view the archive, and no one can alter it.

For migrations into a live system, risk-tiered testing keeps effort sensible. Our article on [GxP data migration validation with risk based tiers](https://blog.qualitum.ai/data-migration-validation) explains how to prove that migrated data keeps its meaning, not only its values.

### 5. Test the archive the way an inspector would

A well-run retrieval exercise is the most persuasive evidence you can generate. Pick a sample of records across years, record types and users. Ask someone who did not run the migration to retrieve each record and reconstruct a decision from it: who did what, when, and why. If they can, document it. If they cannot, you found the gap before the auditor did.

### 6. Close with a disposition plan and final report

The project is incomplete until a records disposition plan is final. It should state where each record class lives, how long it is retained, who may authorize destruction, and how inactive records are kept out of active, validated production environments. Your final report then summarizes deviations, resolutions, verification results and the quality unit's approval to shut the system down.

Only after that approval should the system be disabled, and only then should hardware be sanitized or disposed of.

## Special cases worth planning for

### Equipment and facilities

When the asset is a piece of manufacturing equipment rather than software, the logic shifts to product risk. Residues, contamination and orphaned qualification records matter more. For process equipment, the FDA's [three-stage process validation lifecycle](https://www.fda.gov/files/drugs/published/Process-Validation--General-Principles-and-Practices.pdf) of design, qualification and continued verification is the right frame: record how the equipment performed through its last use, then document that its removal does not leave the validated process uncontrolled. If you are unsure which activities count as qualification and which as validation, our [qualification vs validation guide](https://blog.qualitum.ai/qualification-vs-validation) separates them. For cleaning and sterilization assets, see our pieces on a [risk based cleaning validation strategy](https://blog.qualitum.ai/cleaning-validation-strategy) and [sterilization validation](https://blog.qualitum.ai/sterilization-validation).

### Medical device quality systems

Device makers face a shifting framework as FDA aligns its quality system regulation with ISO 13485. If you retire a quality system tool during that transition, check that your record retention logic maps to the requirements that will apply. A [comparison of ISO 13485 and 21 CFR 820 under the QMSR shift](https://herbilabs.co.uk/iso-13485-vs-21-cfr-820) is a useful starting reference for that mapping.

### Cloud and SaaS systems

Retiring a hosted system adds a dependency: the vendor. The EMA concept paper on revising Annex 11 notes that for critical systems run by service providers, expectations should [go beyond a formal agreement existing](https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/concept-paper-revision-annex-11-guidelines-good-manufacturing-practice-medicinal-products-computerised-systems_en.pdf), including access to complete documentation. Negotiate data export formats, audit trail export and the vendor's deletion evidence into the exit clause before you need them. Our guide to [FDA-aligned cloud validation](https://blog.qualitum.ai/cloud-validation-fda) covers the wider lifecycle.

## Where decommissioning projects go wrong

These are patterns we see repeatedly in validation work:

- **Metadata lost in a convenient export.** A CSV of results looks complete, yet the audit trail, units or signature history stayed behind.
- **No owner after go-live of the replacement.** The old system is "someone else's problem" and periodic review quietly stops.
- **Retention periods guessed rather than mapped.** Different record types have different clocks. One blanket number is a red flag.
- **Legacy data mixed into the new system.** Inactive records re-enter a validated environment without being assessed.
- **Evidence stored in the system being retired.** The plan, protocol and report themselves need a home that outlasts the system.

Each of these is a data integrity problem as much as a project problem. Our [data integrity compliance playbook](https://blog.qualitum.ai/data-integrity-compliance) shows how ALCOA+ principles apply across the record lifecycle, including its tail end.

## Why automation is moving into retirement

The EMA's Annex 11 concept paper signals a preference for technical, automated controls over manual ones when securing data integrity. For decommissioning, that points toward validated archival interfaces and away from hand-built migrations done under deadline pressure. Spreadsheets, screenshots and manually assembled reconciliation packages are slow to author and hard to defend.

The documentation burden is the quiet tax on every retirement. A single system may need a plan, risk assessment, migration protocol, traceability matrix, execution evidence, deviation handling and a final report. Teams usually write these once, under time pressure, for a system nobody wants to touch again.

## Our perspective

We build validation tooling, so we see decommissioning from the documentation side. Retirement is the part of the lifecycle that gets the least attention and the shortest budget, yet it is where an inspector's questions are hardest to answer. The system is gone, the people who ran it have moved on, and the evidence has to speak for itself.

Our view is that every record in a retirement package should be checked for ALCOA+ attributes when it is written and again when it is reviewed, and that traceability from requirement to evidence should be live rather than rebuilt at the end. Human signatures stay authoritative. Automation drafts, cross-checks and flags gaps. People decide.

We also think retirement deserves the same lifecycle thinking as a new deployment. A decommissioning plan written at go-live, with exit criteria and export formats agreed up front, is far cheaper than one improvised years later.

> *— Matt*

## Where Qualitum fits

If your team is staring at a backlog of retirements alongside new deployments, our platform handles the authoring and traceability work in your own environment. Validate·AI drafts protocols and reports and keeps a live traceability matrix, while Operate·AI supports ongoing lifecycle activity such as deviations and CAPA. You can review both on the [platform page](https://qualitum.ai/platform/), or start with a paid [pilot](https://qualitum.ai/) on one system to see how it performs on your own records. For teams concerned about deployment, our [validated SaaS deployment guide](https://blog.qualitum.ai/validated-saas-deployment) describes a 30 to 90 day path.

## FAQ

### What does it mean to decommission a system?

It means planning and carrying out the removal of a system from active use. In GxP settings, that includes identifying and migrating active records, archiving inactive ones, and documenting each step. Records are only deleted after migration is verified and the quality unit has approved.

### Is decommissioning the same as retirement?

Not quite. Decommissioning takes the system out of active use, while retirement is final disposal of the system and its records. Periodic review should continue for a decommissioned system that has not been formally retired, and a final comprehensive review belongs at retirement.

### Do we need to keep audit trails after decommissioning?

Yes. Audit trails are expected to be kept at least as long as the electronic records they relate to. Archive them together with the records, linked so a reviewer can reconstruct who changed what and when.

### How do you prove migrated data is complete?

Combine reconciliation of record counts and key fields with integrity checks such as checksums, then run a retrieval test where an independent reviewer reconstructs real records from the destination. Document the results, deviations and approval in the final report.

### Do we have to keep the legacy application running?

Not necessarily, but you must be able to show the records remain complete and readable for the retention period. Where keeping obsolete software is impractical, validating the archival process is the accepted route. Confirm the approach with your quality unit and, where relevant, your regulatory affairs lead.

## Sources

- [FDA Staff Manual Guide SMG 3291.13, electronic information system records requirements](https://www.fda.gov/media/179376/download)
- [EU GMP Annex 11: Computerised Systems](https://health.ec.europa.eu/document/download/40231f18-e564-4043-94de-c031f813d38b_en)
- [SQA comments on the Annex 11 revision](https://sqa.org/common/Uploaded%20files/1-regulatory%20resources/regulatory%20communications/2021%20-/RRT_EMA-PICs_Annex11Rev_FINAL_2025-10-06.pdf)
- [FDA: Computer Software Assurance for Production and Quality Management System Software](https://www.fda.gov/media/188844/download)
- [FDA: Guidance for Industry, Computerized Systems Used in Clinical Trials](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/fda-bioresearch-monitoring-information/guidance-industry-computerized-systems-used-clinical-trials)
- [FDA: Process Validation, General Principles and Practices](https://www.fda.gov/files/drugs/published/Process-Validation--General-Principles-and-Practices.pdf)
- [EMA: Concept paper on the revision of EU GMP Annex 11](https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/concept-paper-revision-annex-11-guidelines-good-manufacturing-practice-medicinal-products-computerised-systems_en.pdf)

## Recommended

- [Prevent 483s: Risk Based CMMS Validation for GxP QA Teams](https://blog.qualitum.ai/cmms-validation)
- [30–90 Day Inspection Ready Validated SaaS Deployment for Pharma QA](https://blog.qualitum.ai/validated-saas-deployment)
- [Prove Meaning in GxP Data Migration Validation With Risk Based Tiers](https://blog.qualitum.ai/data-migration-validation)
- [Backup Restore Validation for GxP Systems: What Auditors Want](https://blog.qualitum.ai/backup-restore-validation)

## FAQ
### What does it mean to decommission a system?
It means planning and carrying out the removal of a system from active use. In GxP settings, that includes identifying and migrating active records, archiving inactive ones, and documenting each step. Records are only deleted after migration is verified and the quality unit has approved.

### Is decommissioning the same as retirement?
Not quite. Decommissioning takes the system out of active use, while retirement is final disposal of the system and its records. Periodic review should continue for a decommissioned system that has not been formally retired, and a final comprehensive review belongs at retirement.

### Do we need to keep audit trails after decommissioning?
Yes. Audit trails are expected to be kept at least as long as the electronic records they relate to. Archive them together with the records, linked so a reviewer can reconstruct who changed what and when.

### How do you prove migrated data is complete?
Combine reconciliation of record counts and key fields with integrity checks such as checksums, then run a retrieval test where an independent reviewer reconstructs real records from the destination. Document the results, deviations and approval in the final report.

### Do we have to keep the legacy application running?
Not necessarily, but you must be able to show the records remain complete and readable for the retention period. Where keeping obsolete software is impractical, validating the archival process is the accepted route. Confirm the approach with your quality unit and, where relevant, your regulatory affairs lead.
